MLMaw-Sheng Lee

Maw-Sheng Lee

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Maw-Sheng Lee has a total of 147 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Clinical Significance of Abnormal First-Trimester Chorionic Villus Sampling After Mosaic Embryo Transfer: A Prospective Study with Confirmatory Amniocentesis

    by Pin-Yao Lin, Chun-I Lee, En-Hui Cheng, Yi-Ping Pai, Chun-Chia Huang, Ming-Jer Chen, Tzu-Ning Yu, Wei-Che Lo, Tsung-Hsien Lee, Maw-Sheng Lee

    Background/Objectives: Prenatal outcomes after mosaic embryo transfer are generally reassuring. However, evidence remains limited on how an abnormal first-trimester chorionic villus sampling (CVS) result should be interpreted. We evaluated first-trimester CVS findings after mosaic embryo transfer and examined their relationship with the original preimplantation genetic testing for aneuploidy (PGT-A) results and subsequent amniocentesis. Methods: This prospective observational study included 183 CVS specimens obtained from placentas corresponding to PGT-A-designated mosaic embryos. Uncultured chorionic villi were analyzed using the same next-generation sequencing platform used for PGT-A. Abnormal CVS findings were compared with the original PGT-A results, and all nine pregnancies with an abnormal CVS result underwent diagnostic amniocentesis. Results: Of the 183 CVS specimens, 174 (95.1%) were euploid and nine (4.9%; exact 95% confidence interval, 2.27–9.13%) were abnormal. Among the nine abnormal findings, three involved the same chromosome or chromosomal region reported by PGT-A, whereas six involved a different chromosome or region. Amniocentesis showed a euploid result in eight cases, which were classified as confirmed confined placental mosaicism. In the remaining case, mosaicism was also detected in amniotic fluid and was classified as confirmed fetal mosaicism. Conclusions: This is the largest published series specifically evaluating first-trimester CVS after mosaic embryo transfer. Abnormal CVS findings were uncommon, and eight of the nine abnormal findings were confined to the placenta. Furthermore, six involved a chromosome or chromosomal region different from that reported by PGT-A. Therefore, an abnormal CVS result does not necessarily indicate fetal involvement or persistence of the original PGT-A abnormality. Amniocentesis is required to clarify the fetal chromosomal status.

  • Open Access

    Spindle-to-oocyte light retardance ratio as a noninvasive biomarker for oocyte quality assessment: a prospective cohort study

    by Chun-I Lee, Hsiu-Hui Chen, Wei-Che Lo, Chun-Chia Huang, Tsung-Hsien Lee, Pin-Yao Lin, Ming-Jer Chen, Kuang-Han Chao, Maw-Sheng Lee, Chien-Hong Chen

    Background: Polarized light (PL) imaging provides a noninvasive strategy to assess oocyte quality and maturity. This prospective study aims to identify PL parameters in metaphase II (MII) oocytes that serve as adjunctive indicators for usable blastocyst formation. Methods: From August 2024 to August 2025, we studied 581 mature oocytes from women aged ≤ 38 years undergoing autologous in vitro fertilization cycles at Lee Women’s Hospital. Before intracytoplasmic sperm injection, we used PL microscopy to measure birefringence signals in the spindle and zona pellucida (ZP). Fertilized embryos were cultured in a time-lapse (TL) system. We then categorized the oocytes into groups based on their birefringence signals to compare their developmental potential. Results: Through PL imaging, we identified the oocytes with superior developmental competence. Oocytes with a visible MII spindle achieved significantly higher developmental rates—notably for usable blastocyst development—than did those without an MII spindle (46.1% vs. 15.6%). MII oocytes with high spindle and ZP birefringence demonstrated the highest usable blastocyst rate (53.7%) and spindle-to-oocyte light retardance ratio (SOLRR; 0.011 ± 0.003). In multivariate analysis, SOLRR and anti-Müllerian hormone were significant positive and negative predictors of usable blastocyst formation (adjusted odds ratios = 1.148 and 0.939, respectively). SOLRR alone demonstrated moderate predictive power (area under the receiver operating characteristic curve = 0.63). Oocytes with high SOLRR (≥0.01127) consistently outperformed those with low SOLRR (<0.01127), achieving a higher usable blastocyst rate (61.8% vs. 38.0%). In TL analysis, the high SOLRR group demonstrated faster embryonic progression than the low SOLRR group did, indicated by faster blastocyst formation (108.2 vs. 111.2 h) and blastocoel expansion (8.7 vs. 10.2 h); this group also achieved a higher nonreverse cleavage rate (95.4% vs. 86.8%) and superior trophectoderm morphology (58.0% vs. 40.7%). Conclusions: PL imaging can be used to identify oocytes with superior developmental potential. SOLRR serves as an exploratory but quantifiably objective indicator of oocyte competence, independently predicting oocytes with relatively high usable blastocyst formation rates, rapid embryonic progression, and improved trophectoderm morphology.

  • Open Access

    Double Zona Drilling for Trophectoderm Biopsy: A Safe Strategy When Inner Cell Mass Herniates

    by En-Hui Cheng, Yi-Pin Lin, Maw-Sheng Lee, Chi-Ying Lee, Pin-Yao Lin, Chun-Chia Huang, Wei-Che Lo, Chung-I Chen, Ming-Jer Chen, Chun-I Lee

    Background/Objectives: Laser-assisted zona pellucida (ZP) drilling on day 4 embryos is routinely performed in IVF laboratories to facilitate trophectoderm (TE) herniation for blastocyst biopsy. Nevertheless, inner cell mass (ICM) herniation through the initial ZP opening occasionally occurs and may interfere with standard TE biopsy. Methods: This retrospective study assessed the clinical and obstetric safety of a double ZP drilling strategy for TE biopsy in preimplantation genetic testing for aneuploidy (PGT-A) cycles. A total of 560 single euploid embryo transfer cycles were analyzed. Blastocysts were categorized (Groups 1–6) based on ICM/TE herniation patterns and the corresponding biopsy approach. Clinical outcomes were compared between cycles undergoing TE biopsy through a single ZP opening (TE hatching with ICM remaining within the ZP) and cycles requiring a second opening to relocate the biopsy site when the ICM herniated through the original opening or was positioned externally. Results: The single-opening approach of Group 1 accounted for 295 cycles (52.7%), with implantation, miscarriage, and live birth rates of 65.4%, 14.0%, and 56.3%, respectively. The double-opening approach of Group 3 was applied in 21 cycles (3.8%), yielding implantation, miscarriage, and live birth rates of 66.7%, 0%, and 66.7%, respectively. No significant differences were observed between the two strategies in implantation, miscarriage, or live birth rates. Obstetric and neonatal outcomes, including gestational age, birth weight, and monozygotic twinning incidence, were comparable. Fifteen healthy infants were delivered following TE biopsy using the double-opening strategy. Conclusions: These data support incorporating ICM position into TE biopsy decision-making and suggest that creating a second ZP opening to reposition the biopsy site is clinically feasible and does not compromise reproductive or obstetric outcomes in PGT-A cycles.

  • Open Access

    Pathway-Level Convergence Between Dynamic Plasma miRNAs and Endometrial Biological Processes During the Human Peri-Implantation Window

    by Chun-I Lee, An Hsu, Yu-Jen Lee, En-Hui Cheng, Chi-Ying Lee, Pin-Yao Lin, Maw-Sheng Lee, Chung-I Chen, Tzu-Ning Yu, Tiffany Wang, et al.

    The peri-implantation window is a tightly regulated temporal phase during which the human endometrium undergoes coordinated molecular remodeling to establish receptivity. MicroRNAs (miRNAs) contribute to implantation-related processes; however, whether dynamic endometrial regulatory signals are functionally reflected in circulation within a defined temporal framework remains unclear. We hypothesized that although individual miRNA identities differ between endometrial tissue and plasma, temporally regulated miRNAs in both compartments may exhibit overlap at the level of enriched biological pathways during the peri-implantation window. To test this hypothesis, we performed time-resolved small RNA sequencing on paired endometrial and plasma samples collected from 62 participants across progesterone exposure days P+3 to P+7 in hormonally controlled cycles. Temporal modeling identified 27 dynamic miRNAs in endometrial tissue and 17 in plasma (FDR < 0.05). Despite limited overlap at the individual miRNA level, functional enrichment analysis revealed recurrent overlap in apoptosis-, cell cycle-, aging-, inflammatory-, and metabolic-related pathways across compartments. Four miRNAs exhibited concordant directional temporal trends between tissue and plasma with moderate correlation coefficients. These findings suggest that dynamic miRNA-associated enrichment patterns during the peri-implantation window may exhibit pathway-level overlap despite divergence in specific molecular identities. This temporally aligned integrative framework provides a pathway-centric perspective for interpreting cross-compartment miRNA-associated temporal patterns and supports a hypothesis-generating systems-level view of human implantation biology.

  • Open Access

    Factors influencing oocyte yield and embryo quality in donor IVF cycles: a retrospective cohort study

    by Pin-Yao Lin, Chun-I Lee, Hsiu-Hui Chen, Chun-Chia Huang, Ming-Jer Chen, Tzu-Ning Yu, Tsung-Hsien Lee, Maw-Sheng Lee

    Background: Achieving an optimal balance between oocyte yield and embryo quality is central to donor IVF. Although anti-Müllerian hormone (AMH) predicts oocyte quantity, donor characteristics and stimulation parameters may influence embryo developmental competence. We aimed to identify clinical and protocol-related factors associated with oocyte yield and embryo quality in a large donor cohort. Methods: We retrospectively analyzed 584 donor IVF cycles at a single center (Jan 1, 2018–Dec 31, 2023). Donor variables included age, AMH, BMI (body mass index), and baseline hormones. Stimulation used gonadotropin-releasing hormone (GnRH) antagonist (27.1%) or progestin-primed ovarian stimulation (PPOS)(72.9%); recombinant human luteinizing hormone (LH) was used in 86% of cycles; final maturation was GnRH agonist (GnRHa) (59.4%) or dual trigger (40.6%). Outcomes were oocyte yield and embryo quality metrics (maturation, two-pronuclear (2PN) fertilization, Day 3 good-quality embryo rate, blastocyst formation rate, and top-quality blastocyst rate). Multivariable linear regression and propensity score matching (PSM) compared protocols and LH supplementation. Results: Donors were 25.6 ± 3.7 years with AMH 6.1 ± 2.9 ng/mL and BMI 21.6 ± 2.8 kg/m². Per cycle: 27.1 ± 11.1 oocytes, 20.8 ± 8.3 MII (maturation 78.2 ± 13.4%), 2PN fertilization 73 ± 18%, Day 3 good-quality embryos 10.6 ± 6.0 (69.5 ± 23.5%), blastocysts 9.5 ± 5.5 (56.7 ± 22.5%), and top-quality blastocysts 6.1 ± 4.2 (36.5 ± 20.1%). First transfers (n=491) yielded 55.4% clinical pregnancy and 44.4% live birth; miscarriage 12.2%. AMH independently predicted oocyte number; higher BMI was associated with lower fertilization. PPOS produced lower Day 3 good-quality embryo (67.9% vs 72.8%) and top-quality blastocyst rates (59.7% vs 74.1%) versus antagonist in PSM, with similar blastocyst formation rate (64.0% vs 60.9%). LH supplementation modestly increased fertilization (74.4% vs 69.5%) without downstream differences. Dual trigger was associated with reduced blastocyst formation rate but a higher proportion of top-quality blastocysts. Conclusions: In donor IVF, AMH is the principal predictor of oocyte yield, whereas BMI, stimulation protocol, and trigger method influence embryo quality. Despite protocol-dependent morphology differences, pregnancy and live birth rates remained high. Findings support individualized stimulation strategies that consider donor profile and protocol effects to optimize efficiency and outcomes.


  • Open Access

    The Dynamic Change of microRNA Expression Profile in Endometrium and Plasma During the Periimplantation Window

    by Chun-I Lee, An Hsu, Yu-Jen Lee, En-Hui Cheng, Pin-Yao Lin, Maw-Sheng Lee, Chung-I Chen, Tzu-Ning Yu, Tiffany Wang, Cai-Yun Wang, et al.

    Background: MicroRNAs (miRNAs) regulate gene expression critical for embryo implan-tation, but integrated analyses of miRNA changes in both endometrium and plasma dur-ing the peri-implantation period are lacking. Methods: A total of 62 endometrium and 62 plasma samples were collected from participants undergoing hormone treatment cycles between day P+3 to P+7. Next-generation sequencing (NGS) assay was used to profile miRNA expression levels. To identify the dynamic differentially expressed (DE) miRNAs, we compared the following groups: P+3/P+4, P+4/P+5, P+5/P+6, and P+6/P+7. Then, we perform functional miRNA-target interaction (MTI) and pathway enrichment analysis to understand the biological functions of DE miRNAs. Results: A total of 76 DE miRNAs in endometrium and 48 in plasma were identified. These miRNAs are involved in pathways related to implantation, such as cell senescence, cell growth, apoptosis, focal adhesion, autophagy, platelet activation and signaling. Ten DE miRNAs overlapped between en-dometrial tissue and plasma, with seven showing consistent dynamic expression changes. Further analysis revealed a high similarity in the biological pathways and functions in-volving the target genes of DE miRNAs in both endometrium and plasma. Conclusions: Dynamic miRNA expression changes in both endometrium and plasma reflect key bio-logical processes regulating human embryo implantation.

  • Open Access

    Improved clinical outcomes with a modified warming protocol in donor oocyte cycles

    by Chun-I Lee, Hsiu-Hui Chen, Shu-Hui Lin, Chun-Chia Huang, Pin-Yao Lin, Tsung-Hsien Lee, Ming-Jer Chen, Maw-Sheng Lee, Chien-Hong Chen

    Recent studies have attempted to improve laboratory efficiency while preserving clinical outcomes by shortening the time to warm cryopreserved embryos, though it is still unclear for oocytes. This study thus aimed to evaluate the effects of a modified warming protocol (MWP) on embryonic development and pregnancy outcomes of vitrified donor oocytes. The data of this retrospective cohort study were collected from women who underwent donor cycles (fresh or vitrified oocytes) at Lee Women's Hospital, Taiwan, from January 2019 to August 2024. The sample included 13,103 donor oocytes, divided into three groups: conventional warming protocol (CWP) group (n = 8506), MWP group (n = 980), and fresh group (n = 3617). Survival rates after oocyte warming were similar between the CWP and MWP groups (93.7% vs. 93.9%, P > 0.05). Oocyte degeneration rates post-intracytoplasmic sperm injection (ICSI) were similar for vitrified-warmed and fresh oocytes (2.7-3.4% vs. 2.8%). Normal fertilization was lower for vitrified-warmed oocytes (79.5-79.6% vs. 83.0%, P < 0.05), while abnormal fertilization was higher (9.1-10.1% vs. 3.3%). Blastocyst formation and usable blastocyst formation were lower in the CWP group (57.5% and 35.4%) compared to MWP (77.3% and 51.4%) and fresh groups (69.2% and 48.5%). Ongoing pregnancy/live birth was higher in the MWP group than in the CWP group (66.7% vs. 50.4%, P < 0.05). Multivariate analysis showed a positive association between MWP and usable blastocyst formation (adjusted incidence rate ratio = 1.423, 95% CI = 1.268 to 1.597, P < 0.001), as well as ongoing pregnancy/live birth (adjusted odds ratio = 1.899, 95% CI = 1.002 to 3.6, P < 0.05). This study suggests that the MWP enhances the blastocyst formation potential and pregnancy outcomes of vitrified-warmed oocytes, making it similar to that of fresh oocytes. Thus, the MWP may replace the CWP as the standard protocol for optimizing donor cycle outcomes. Not applicable.


  • Open Access

    A four-year, mixed-family and community-based growth monitoring and promotion program using multi-level modeling to address undernutrition in children in Cambodia

    by Po-Yen Liu, Yen-Ting Lin, Yee-Hsuan Chiou, Maw-Sheng Lee

    Introduction: Child undernutrition persists as a formidable public health issue in developing countries. Children afflicted by undernutrition are susceptibility to both physical and neurological repercussions. For several decades, initiatives focused on growth monitoring and promotion have been instituted to mitigate this pressing issue. Nevertheless, the prevalence rates of undernutrition across developing nations continue to provoke concern.Methods: Between the years 2016 and 2019, we executed a family- and community-oriented growth monitoring and promotion initiative within a rural Cambodian village, specifically aimed at children under the age of five. This initiative employed a hybrid workforce comprising both full-time health professionals and community volunteers. Leveraging this robust capacity, we delivered small-group nutrition education sessions, family-centered nutrition counseling, and regular anthropometric assessments. In contrast to a cross-sectional methodology, we used multi-level modeling to explore the growth trajectories of children utilizing longitudinal z scores for height-for-age and weight-for-age. A systematic taxonomy of models was developed in a sequential framework to ascertain the most appropriate final model.Results: Out of 533 enrolled children, 358 completed the growth monitoring program (GMP). At baseline, children older than 12 months had significantly lower height-for-age (HAZ) and weight-for-age (WAZ) scores, as well as higher rates of stunting and wasting, compared to younger children. These differences were no longer significant by the end of the program. Nonparametric trajectory analyses showed age-related differences in HAZ patterns, with initial declines followed by recovery in younger age groups, while WAZ trajectories remained relatively flat across all ages. Multilevel modeling indicated that both age at enrollment and time significantly influenced HAZ changes, while only age at enrollment affected WAZ. Older children exhibited steeper improvements over time, leading to convergence in growth outcomes with younger children.Conclusion: An extended and efficacious growth monitoring and promotion program has the potential to ameliorate the issue of undernutrition in developing countries.


  • Open Access

    Assessing the Viability of Segmental Aneuploid Embryos: A Chromosomal Concordance Study of 175 Human Blastocysts

    by En-Hui Cheng, Hui-Hsin Shih, Tsung-Hsien Lee, Pin-Yao Lin, Tzu-Ning Yu, Chun-Chia Huang, Maw-Sheng Lee, Chun-I Lee

    Preimplantation genetic testing for aneuploidy (PGT-A) is widely used to select euploid embryos for in vitro fertilization (IVF), but its accuracy in predicting the implantation potential for full segmental aneuploid (Seg-A) embryos remains unclear. In this study, we investigated chromosomal concordance between clinically biopsied trophectoderm (TE) and inner cell mass (ICM) in 175 donated blastocysts, which comprised those clinically diagnosed as euploid (13), Seg-A (36), segmental mosaicism (Seg-M) (60), whole-chromosome aneuploid (Who-A) (52), and whole-chromosome mosaicism (14). Using next-generation sequencing (NGS), we found that TE–ICM concordance rates were higher for euploid (85%) and Who-A (94%) embryos but significantly lower for Seg-A (25%) and Seg-M embryos (33%). For Seg-A, the euploidy rate in the ICM was 19% and the euploidy rate in the ICM was 63% for Seg-M. These low concordance rates may be due to technical and biological artifacts of PGT-A for Seg-A. Despite the significant discordance between TE and ICM, a subset of Seg-A embryos demonstrated euploidy. While clinically diagnosed euploid embryos remain the preferred choice, Seg-A embryos should be considered as having implantation potential. In particular, Seg-A results should be clearly distinguished from Who-A results and not routinely categorically discarded. Further research is required to refine the selection criteria, aided by parental karyotyping or re-biopsy, and to develop more reliable embryo assessment methods to ensure the accurate evaluation of reproductive potential and support shared decision making between doctors and patients.